濟川藥業(600566.SH):濟川控股解質押1500萬股
格隆匯5月19日丨濟川藥業(600566.SH)公佈,2015年10月20日,濟川控股將其持有的1500萬股公司流通股向中國工商銀行股份有限公司泰興支行進行股票質押。公司於近日接到濟川控股關於股份解質押相關事項的通知,上述1500萬股流通股已在中國證券登記結算有限責任公司辦理完成了相關股權質押解除手續。
截至公告日,公司控股股東江蘇濟川控股集團有限公司(“濟川控股”)持有公司股份4.17億股,佔公司總股本的51.14%,此次解除質押1500萬股後,累計質押公司股份0股。
截至公告日,濟川控股及其一致行動人合計持有公司股份5.64億股,佔公司總股本的69.16%,此次解除質押後,濟川控股及其一致行動人合計累計質押公司股份0股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.